
|Videos|December 15, 2021
iPLEDGE and Isotretinoin: What Happened?
Author(s)Linda Stocum, Associate Editor
In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.
Advertisement
In this first part of a video interview with Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, Peebles explains the history of iPLEDGE and what may have led to the current difficulties that physicians, pharmacies, and patients are dealing with.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















